Technology ID
TAB-2736
Real-time PCR Assays for Human Bocavirus Detection and Diagnosis
E-Numbers
E-213-2013-0
Lead Inventor
Erdman, Dean (CDC)
Co-Inventors
Peret, Teresa (CDC)
Applications
Therapeutics
Research Materials
Occupational Safety and Health
Diagnostics
Consumer Products
Therapeutic Areas
Ophthalmology
Oncology
Infectious Disease
Endocrinology
Dental
Cardiology
Development Stages
Pre-Clinical (in vitro)
Development Status
In vitro data available
Lead IC
CDC
ICs
CDC
CDC researchers have developed a real-time PCR assay for the detection and viral-load quantitative estimations of human bocavirus (HBoV) from clinical specimens. At present, there have been few reports on the epidemiology, geographic distribution or clinical features of HBoV infection. Additionally, symptoms affiliated with bocavirus infections overlap with numerous other respiratory illnesses. This CDC assay provides sensitive, specific, and quantitative detection of HBoV in patients with respiratory illness by a method of real-time PCR targeting the HBoV NS1 and NP-1 genes. Use of this assay in conjunction with additional diagnostic methods and treatments should facilitate improved diagnosis and, subsequently, directed treatment and patient outcome.
Commercial Applications
- Human bocavirus (HBoV) research tools
- Respiratory illness diagnostics and research
- Public health surveillance
- Confirmation/diagnosis of HBoV infection
Competitive Advantages
- Specific and sensitive
- Capable of rapid HBoV detection and distinction from alternate respiratory-illness linked pathogens
- Superior to other HBoV detection methods in cost-efficiency, accuracy and quantitation of viral load
Licensing Contact: